Peters Richard
- SEC CIK
- 0001697628
No open-market purchases or sales filed in the past year.
Current role at each company
- APRE Aprea Therapeutics, Inc.Directoras of Jun 17, 2026
- KA Kineta, Inc.Directoras of Jul 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Peters Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APRE Aprea Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Peters RichardDirector | PPurchase | +247.8K | $0.81 | +$100.4K | –123.9K after | Derivative2 lots |
KA Kineta, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Peters RichardPresident and CEO | SSale | −10.9K | $1.69 | −$18.4K | −10.8%90.0K after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Peters RichardPresident and CEO | SSale | −4.58K | $1.85 | −$8.48K | −4.3%100.9K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Peters RichardPresident and CEO | SSale | −10.2K | $1.19 | −$12.1K | −8.8%105.5K after | |
| Mar 30, 2022 (view filing) | Mar 28 | 2 days | Peters RichardPresident and CEO | SSale | −10.7K | $1.85 | −$19.8K | −8.5%115.7K after |